Blue Owl logo

Blue Owl

Crunchbase
Pitchbook
Crunchbase

Deals on record

8

Common Fundraising Type

Equity

Databricks logo
Databricks

Data and AI

JPMorgan logo
Blackstone logo
Blue Owl Capital logo
Apollo Global Management logo

Databricks is a data and AI company that provides a platform utilized by over 10,000 organizations globally, including more than half of the Fortune 500 companies, and has completed a Series I funding round to accelerate AI technology development and expand its team.

Debt
$5.3B
01/15/2025
Article
Windward Bio logo
Windward Bio

Drug development

Novo Holdings logo
OrbiMed logo
RTW Investments logo
Qiming Venture Partners logo
Quan Capital logo
Pivotal bioVenture Partners logo
Omega Funds logo
SR One logo

Windward Bio is a clinical-stage drug development company focused on creating treatments for severe respiratory conditions, including asthma and COPD, using long-acting monoclonal antibodies and bispecifics.

Series A
$200M
01/10/2025
Article

Aviceda Therapeutics is a biotech company developing next-generation immunomodulators for ophthalmic conditions using its proprietary HALOS™ nanotechnology platform.

Series C
$207.5M
01/07/2025
Article
Splitero logo
Splitero

Financial technology

Blue Owl Managed Funds logo

Splitero provides homeowners with innovative solutions to access their home equity without taking on new debt or monthly payments.

Equity
$350M
12/09/2024
Article
Nuvig Therapeutics logo
Nuvig Therapeutics

Biotechnology

Sanofi Ventures logo
Blue Owl Healthcare Opportunities logo
Norwest Venture Partners logo
Novo Holdings logo
Mission BioCapital logo
LOTTE Holdings logo
Leaps by Bayer logo
Global BioAccess Fund logo

Nuvig Therapeutics is a biotechnology company developing treatments for autoimmune diseases that do not rely on immunosuppression.

Series B
$161M
12/05/2024
Article
Nuvig Therapeutics logo
Nuvig Therapeutics

Biotechnology

Sanofi Ventures logo
Blue Owl Healthcare Opportunities logo
Norwest Venture Partners logo
Novo Holdings logo
Mission BioCapital logo
LOTTE Holdings logo
Leaps by Bayer logo
Global BioAccess Fund logo

Nuvig Therapeutics is a biotechnology company developing treatments for autoimmune diseases that do not rely on immunosuppression.

Series B
$161M
12/05/2024
Article
Interos logo
Interos

Supply chain

Blue Owl Capital logo

Interos provides AI-driven supply chain risk intelligence solutions to help organizations map and monitor potential risks.

Equity
$40M
10/24/2024
Article
Vestwell logo
Vestwell

Fintech

Primary Venture Partners logo
Lightspeed Venture Partners logo
HarbourVest logo
FinTech Collective logo
Fin Capital logo
Blue Owl logo

Vestwell is a fintech company that provides a cloud-native platform for financial institutions, state governments, and payroll companies to offer workplace savings programs such as 401(k), 403(b), IRA, and 529 Education plans.

Equity
$125M
12/21/2023
Article